Published
EMA recommends Covid-19 Vaccine AstraZeneca for authorisation in the EU
The European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation for Covid-19 Vaccine AstraZeneca.
Share this content:
This is the third Covid-19 vaccine to be approved by the European Commission.
EMA's evaluation of the vaccine has shown that it meets the EU's requirements for safety, efficacy, quality and manufacturing.